← Eichor
Condition: Intermediate Risk Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Intermediate Risk

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Phase 2 · 4 location(s) · Yale University · NCT06111781Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
Phase 2 · 1 location(s) · University of Rochester · NCT05597345Renal Adjuvant MultiPle Arm Randomised Trial
Phase 3 · 35 location(s) · University College, London · NCT03288532SRT Versus SRT+ADT in Prostate Cancer
Phase 3 · 1 location(s) · Marco Lorenzo Bonu · NCT05019846Application of Machine Learning Models to Reduce Need for Diagnostic EUS or MRCP in Patients With Intermediate Likelihoo
Phase N/A · 1 location(s) · Asian Institute of Gastroenterology, India · NCT06066372The Relationship Between Controlling Risk Factors and Cerebral Haemodynamics in Lacunar Stroke
Phase N/A · 1 location(s) · University of Leicester · NCT06354881The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance
NA · 1 location(s) · NHS Lothian · NCT06117059HAIC Compared With TACE in Huge Hepatocellular Carcinoma
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT06641713Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Phase 4 · 19 location(s) · AOP Orphan Pharmaceuticals AG · NCT06317805Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens
Phase 2/Phase 3 · 56 location(s) · University Hospital, Angers · NCT02416388Lparomlimab and Tuvonralimab Injection in Combination With TACE and Lenvatinib in the Treatment of Second-Line Therapy f
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07099274Evaluation of the Association Between the Effects of Generalized Stage 3 and 4 Periodontitis on Arterial Stiffness and C
NA · 1 location(s) · Nantes University Hospital · NCT07263113Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its
NA · 1 location(s) · Khyber Medical University Peshawar · NCT06561126CARAMEL Observational Study
Phase N/A · 6 location(s) · Biogipuzkoa Health Research Institute · NCT07695376Intermediate-dose HAD Regimen for CEBPA Double-mutated AML
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06529250Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL
Phase 2 · 3 location(s) · Massachusetts General Hospital · NCT04560322Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
Phase 4 · 1 location(s) · Seoul National University Bundang Hospital · NCT07719894Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Can
Phase 3 · 103 location(s) · Ferring Pharmaceuticals · NCT06510374Modifiable Risk Factors for Cognitive Dysfunction in Patients With Coronary Heart Disease
Phase N/A · 1 location(s) · Beijing Anzhen Hospital · NCT07657624Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
Phase 2 · 1 location(s) · Medical University of South Carolina · NCT07513389Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined
Phase N/A · 1 location(s) · Shu Wang · NCT06711068Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy
Phase 2 · 3 location(s) · St. Jude Children's Research Hospital · NCT06023641Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)
Phase 3 · 2 location(s) · Jesper Kjaergaard · NCT06453876Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermed
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06090656ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0
Phase N/A · 1 location(s) · University of Milano Bicocca · NCT07407608A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · 179 location(s) · Takeda · NCT06499285CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma
Phase N/A · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06146764Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
Phase 2/Phase 3 · 27 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06764238Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.
Phase 4 · 4 location(s) · Menzies School of Health Research · NCT07468513An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05454488
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.